21. THU0527 Lesinurad, A Selective Uric Acid Reabsorption Inhibitor, in Combination with Xanthane Oxidase Inhibitors: SUA and Flares Composite Endpoint from Phase III Studies in Gout Patients (Clear 1, Clear 2 and Crystal). (15th July 2016) Authors: Khanna, P.P.; Baumgartner, S.; Robinson, J.; Tafesse, E.; Morlock, R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗